Main Text {#S1}
=========

We chose *Helicobacter hepaticus* (*H. hepaticus*) as a model to investigate host-pathobiont interplay. IL-10RA blockade induced inflammation of the large intestine (LI) in *H. hepaticus*-colonized *Il23r^GFP^* reporter mice^[@R5],[@R6]^, increasing GFP^+^ cells (predominantly T~H~17) from \~10% to \~50% of LI CD4^+^ T cells ([Extended Data Fig. 1a](#F5){ref-type="fig"}). Therefore we wished to determine why *H. hepaticus*-induced T cells do not cause disease in wild-type (WT) animals at steady state. To tackle this question, we first identified the T cell receptor (TCR) sequences and cognate epitopes of *H. hepaticus*-induced T~H~17 cells that expand during inflammation, and subsequently traced the fate of these cells at steady state.

We cloned individual T cell receptor (TCR) sequences from colitogenic IL-23R-GFP^+^ T cells ([Extended Data Fig. 1b](#F5){ref-type="fig"}) and found that nine out of twelve clonotypic TCRs were *H. hepaticus-*specific ([Extended Data Fig. 1c](#F5){ref-type="fig"}). We subsequently identified^[@R7],[@R8]^ a *H. hepaticus-*unique protein, HH_1713 containing two immunodominant epitopes. The E1 peptide epitope, presented by I-A^b^, was recognized by *H. hepaticus*-specific TCR HH5-1, whereas E2 was recognized by TCR HH5-5, HH6-1 and HH7-2 ([Extended Data Fig. 1c](#F5){ref-type="fig"}). We next developed two complementary approaches to track *H. hepaticus*-specific T cells *in vivo*^[@R9],[@R10]^, HH7-2 and HH5-1 TCR transgenic mice (HH7-2tg and HH5-1tg) and a MHCII-tetramer loaded with E2 peptide (HH-E2 tetramer) ([Extended Data Fig. 1d--g](#F5){ref-type="fig"}).

To track what happens to *H. hepaticus*-specific T cells in healthy animals, we simultaneously transferred naïve HH7-2tg and 7B8tg (segmented filamentous bacteria (SFB)-specific TCRtg control)^[@R8]^ T cells into WT mice that were stably colonized with *H. hepaticus* and SFB ([Fig. 1a](#F1){ref-type="fig"}). Two weeks post adoptive transfer, HH7-2tg donor cells were enriched in the large intestinal lamina propria (LILP) and cecal patch (CP), whereas 7B8tg cells predominated in the small intestinal lamina propria (SILP) and Peyer's patches (PPs) ([Extended Data Fig. 2a, b](#F6){ref-type="fig"}), consistent with colonization of *H. hepaticus* in the LI and SFB in the SI. As previously reported, 7B8 cells developed into T~H~17 cells that were largely positive for RORγt and negative for Foxp3^[@R8]^ ([Fig. 1b, c](#F1){ref-type="fig"}, [Extended Data Fig. 2c, d](#F6){ref-type="fig"}). By contrast, HH7-2tg cells in the LILP were mostly iT~reg~ expressing both RORγt and Foxp3 (\~60% of total donor-derived HH7-2tg cells)^[@R11],[@R12]^, rather than T~H~17 cells (\<10% of total HH7-2tg cells) ([Fig. 1b, c](#F1){ref-type="fig"}, [Extended Data Fig. 2c, d](#F6){ref-type="fig"}). Notably, two other colonic T~reg~ markers, GATA3 and ST2, were not expressed on HH7-2tg cells ([Extended Data Fig. 2e](#F6){ref-type="fig"})^[@R13]^. 7B8tg and HH7-2tg T cells expressing neither RORγt nor Foxp3 were mostly T follicular helper (T~FH~) cells and were enriched in the PPs and CP ([Fig. 1b, c](#F1){ref-type="fig"}, [Extended Data Fig. 2c, d](#F6){ref-type="fig"}). Breeding HH7-2tg mice onto the *Rag1*^−/−^ background excluded the possibility that HH7-2tg iT~reg~ cells detected after adoptive transfer were contaminated by thymus-derived natural T~reg~ (nT~reg~) or were influenced by the presence of dual TCRs ([Extended Data Fig. 3a--c](#F7){ref-type="fig"}). Adoptively transferred HH5-1tg and HH-E2-tetramer positive cells had differentiation profiles similar to HH7-2tg cells ([Fig. 1d, e](#F1){ref-type="fig"} and [Extended Data Fig. 2f](#F6){ref-type="fig"} and [3d, e](#F7){ref-type="fig"}). These results indicate that the host responds to *H. hepaticus* by generating immunotolerant iT~reg~ cells rather than pro-inflammatory T~H~17 cells.

To examine if the iT~reg~-dominant differentiation of *H. hepaticus*-specific T cells is altered during intestinal inflammation, we co-transferred naïve HH7-2tg and control 7B8tg T cells into colonized *Il10^−/−^* recipients. Strikingly, only a small proportion of the transferred HH7-2tg T cells expressed Foxp3 in the LILP. Instead, most of them differentiated into pro-inflammatory T~H~17 cells with T~H~1-like features, characterized by expression of both RORγt and T-bet and high levels of IL-17A and IFNγ upon re-stimulation^[@R14]^ ([Fig. 2a--f](#F2){ref-type="fig"} and [Extended Data Fig. 4a, c, d](#F8){ref-type="fig"}). These results were recapitulated with adoptive transfer of HH5-1tg T cells and endogenous HH-E2 tetramer^+^ T cells ([Extended Data Fig. 4e--g](#F8){ref-type="fig"}). By comparison, disruption of IL-10-mediated immune tolerance did not result in deviation of SFB-specific T~H~17 cells to the inflammatory T~H~17-T~H~1 phenotype ([Fig. 2c, d](#F2){ref-type="fig"} and [Extended Data Fig. 4a--d](#F8){ref-type="fig"}). Furthermore, we observed similar deviated T cell responses to *H. hepaticus* in models of T cell transfer colitis and *Citrobacter rodentium (C. rodentium)*-induced colonic inflammation, but not in DSS colitis, an innate immunity-dependent model ([Extended Data Fig. 5a--h](#F9){ref-type="fig"}). Commensal microbe-specific T cells can thus acquire pro-inflammatory phenotypes during enteric infection^[@R15]^, although the high frequency of such infections suggests the existence of a mechanism to re-establish gut tolerance. Our observations of *H. hepaticus*-specific iT~reg~-T~H~17 skewing during colitis are consistent with a contemporaneous study using two different *Helicobacter* species^[@R16]^. These findings indicate that dysregulated T cell tolerance to pathobionts may be a general hallmark of IBD.

We next wished to determine if RORγt^+^ T~reg~ cells are critical for immune tolerance to gut pathobionts. The transcription factor c-Maf attracted our attention as it was highly enriched in these cells^[@R11],[@R17]^ ([Extended Data Fig. 6a](#F10){ref-type="fig"}) and known to promote an anti-inflammatory program e.g. IL-10 expression in other T helper subsets^[@R18],[@R19]^. We therefore deleted *Maf* with *Foxp3^cre^* to test its function in T~reg~. In *H. hepaticus*-colonized *Maf*^fl/fl^;*Foxp3^cre^* (*Maf*^Δ^*^Treg^*) mice, despite incomplete depletion of c-Maf protein ([Extended Data Fig. 6b](#F10){ref-type="fig"}), there was a marked decrease in the proportion of RORγt^+^ but not RORγt^−^ T~reg~ among CD4^+^ T cells in the LI, and a concomitant increase in T~H~17 frequency ([Fig. 3a](#F3){ref-type="fig"}). *Maf*^Δ^*^Treg^* mice also had expanded numbers of total CD4^+^ T cells in the LI, reflected by a pronounced accumulation of T~H~17, but notably not RORγt^+^ T~reg~ ([Extended Data Fig. 6c](#F10){ref-type="fig"}). In contrast, after *H. hepaticus*-colonization, T~H~17 expansion was less striking in *Rorc^fl/fl^*;*Foxp3^cre^* (*Rorc*^Δ^*^Treg^*) mice ([Fig. 3a](#F3){ref-type="fig"}, [Extended Data Fig. 6c](#F10){ref-type="fig"}), and neither a decrease of RORγt^+^ T~reg~ cells nor an expansion of T~H~17 cells was observed in *Gata3^fl/fl^*;*Foxp3^cre^* (*Gata3*^Δ^*^Treg^*) mice ([Extended Data Fig. 6d, e](#F10){ref-type="fig"}). The altered frequency of RORγt^+^ T~reg~ and T~H~17 subsets led us to test if the fate of *H. hepaticus*-specific T cells would be affected in the *Maf*^Δ^*^Treg^* and *Rorc*^Δ^*^Treg^* mice. Strikingly, HH-E2-tetramer^+^ cells were predominantly T~H~17 in *Maf*^Δ^*^Treg^* animals, but mostly RORγt^+^ T~reg~ in control mice ([Fig. 3b](#F3){ref-type="fig"}, [Extended Data Fig. 6f](#F10){ref-type="fig"}). In contrast, although *Rorc*^Δ^*^Treg^* mice also had an increased proportion of *H. hepaticus*-specific T~H~17 cells, the majority of tetramer^+^ cells were T~reg~ ([Fig. 3b](#F3){ref-type="fig"}, [Extended Data Fig. 6f](#F10){ref-type="fig"}). Collectively, these results suggest that pathobiont-specific RORγt^+^ iT~reg~ cells are required for the suppression of inflammatory T~H~17 cell accumulation. While RORγt expression contributes to gut iT~reg~ function, c-Maf plays a more substantial role in the differentiation and/or function of these cells. *H. hepaticus*-specific T~FH~ differentiation in the CP did not appear to be affected in *Maf*^Δ^*^Treg^* animals ([Extended Data Fig. 6g](#F10){ref-type="fig"}). Notably, as in IL-10-deficient mice, SFB-specific T~H~17 neither expanded nor adopted a T~H~1-like phenotype in *Maf*^Δ^*^Treg^* mice ([Extended Data Fig. 6h, i](#F10){ref-type="fig"}). A potential explanation is that SFB- and *H. hepaticus*-specific T~H~17 responses are instructed by different innate immune pathways^[@R20],[@R21]^.

To investigate how c-Maf regulates the gut RORγt^+^ iT~reg~-T~H~17 axis, we co-transferred equal numbers of naïve *Maf^+/+^;Foxp3^cre^* (control) and *Maf^fl/fl^;Foxp3^cre^* HH7-2tg cells into *H. hepaticus*-colonized WT animals ([Extended Data Fig. 7a, b](#F11){ref-type="fig"}). Two weeks after adoptive transfer, the *Maf^fl/fl^;Foxp3^cre^* HH7-2tg cells were markedly underrepresented compared to control cells in the LILP, mLNs and spleen, and were unable to form iT~reg~ ([Fig. 3c--e](#F3){ref-type="fig"} and [Extended Data Fig. 7c,d](#F11){ref-type="fig"}). Importantly, at homeostasis, mutant donor-derived cells did not give rise to a high frequency of T~H~17 ([Fig. 3e](#F3){ref-type="fig"}). Transcriptomics analysis revealed that the c-Maf-deficient iT~reg~ cells were functionally impaired, as indicated by defective expression of *Il10* and other T~reg~ signature genes, as well as of RORγt-dependent genes^[@R11]^ ([Fig. 3f](#F3){ref-type="fig"}, [Extended Data Fig. 7e--h](#F11){ref-type="fig"}). Taken together, these findings show that c-Maf is a critical cell-intrinsic factor for both generation and function of microbe-specific iT~reg~. Notably, the vast majority of accumulated T~H~17 cells in *Maf*^Δ^*^Treg^* animals expressed c-Maf, indicating that the bulk of these cells did not arise from T~reg~ in which c-Maf was deleted ([Extended Data Fig. 7i](#F11){ref-type="fig"}). Thus, suppression of T~H~17 expansion is mediated by these iT~reg~ cells *in trans*.

RORγt expression in iT~reg~ cells has been implicated in the maintenance of gut immune homeostasis under different challenges^[@R11],[@R12]^. However, spontaneous gut inflammation in *Rorc*^Δ^*^Treg^* animals has not been described. We noticed that *Maf*^Δ^*^Treg^*, but not *Rorc*^Δ^*^Treg^* or control littermates, were prone to rectal prolapse ([Fig. 4a](#F4){ref-type="fig"}). *Maf*^Δ^*^Treg^* mice (8--12 weeks) colonized with *H. hepaticus* for five to six weeks had enlarged LI-draining mesenteric lymph nodes (mLN) and increased cellularity of mLNs and LI ([Fig. 4b, c](#F4){ref-type="fig"}). Histopathological analysis of the LI of these animals revealed mixed acute and chronic inflammation ([Fig. 4d](#F4){ref-type="fig"}). Without *H. hepaticus* colonization, aged (6--12 months) *Maf*^Δ^*^Treg^* mice also exhibited mild spontaneous colitis ([Fig. 4e](#F4){ref-type="fig"}). Notably, none of the above changes was observed in *Rorc*^Δ^*^Treg^* mice ([Fig. 4b--d](#F4){ref-type="fig"}). Thus, c-Maf but not RORγt expression in iT~reg~ cells is critical for suppression of spontaneous inflammation. Indeed, the transcriptional profile of *H. hepaticus*-specific T effector (T~Eff~) cells from *Maf*^Δ^*^Treg^* mice with spontaneous colitis was highly similar to that of pathogenic T~H~17 cells in IL-10RA blockade-induced colitis, but differed markedly from homeostatic T~H~17 cells (which are predominantly SFB-specific) ([Extended Data Fig. 8a--f](#F12){ref-type="fig"}).

Similar to the *Maf*^Δ^*^Treg^* strain, mice with inactivation of Stat3 in the T~reg~ compartment or impaired TGFβ signaling in CD4^+^ T cells also lacked RORγt^+^ T~reg~ and developed spontaneous colitis ([Extended Data Fig. 9a, b](#F13){ref-type="fig"})^[@R12],[@R22],[@R23]^. Consistent with these findings, c-Maf expression in T~reg~ required a combination of both TGFβ and Stat3 signals *in vitro* and *in vivo*, as it does in other CD4^+^ T cells ([Extended Data Fig. 9a--c](#F13){ref-type="fig"})^[@R18],[@R19]^. This suggests that c-Maf integrates anti-inflammatory TGFβ receptor signals with microbe-induced cytokine-dependent Stat3 activation to mediate RORγt^+^ T~reg~ induction.

Although c-Maf is also expressed, albeit at a lower level, in nT~reg~ cells, c-Maf-deficient and -sufficient nT~reg~ showed equivalent activity in inhibiting T~Eff~ cell proliferation *in vitro*, as well as in suppressing pathogenesis in a model of T cell transfer colitis *in vivo* ([Extended Data Fig. 10a, b](#F14){ref-type="fig"}). We therefore wondered why, despite their increased numbers ([Extended Data Fig. 6c](#F10){ref-type="fig"}), nT~reg~ cells were not sufficient to establish gut homeostasis in *Maf*^Δ^*^Treg^* mice. Adoptive transfer of 1,000 naïve HH7-2tg or HH5-1tg cells into *H. hepaticus*-colonized *Rag1*^−/−^ mice led to colitis. Taking advantage of this system, we compared the suppressive function of iT~reg~ cells differentiated *in vitro* from naïve HH7-2tg, HH5-1tg and polyclonal T cells. We found that epitope-specific iT~reg~ were better at suppressing colitis, providing a potential explanation for why pathobiont-specific iT~reg~ are required in addition to nT~reg~ to maintain gut homeostasis^[@R24]^ ([Fig. 4f, g](#F4){ref-type="fig"}).

Our results reveal a mechanism for how a healthy individual can host a "two-faced" commensal pathobiont like *H. hepaticus* without developing inflammatory disease. Our findings suggest that T~reg~ induction serves as a strategy to establish commensalism, not only by helping the microbes to colonize their niche^[@R25]^, but also by protecting the host from inflammation. A similar requirement for iT~reg~ has also been reported in the establishment of food tolerance^[@R26]^. Our observations in *Maf*^ΔTreg^ mice are linked to and help explain the expansion of colitogenic T~H~17 cells in mice with T~reg~-specific inactivation of Stat3^[@R23]^. Like c-Maf, Stat3 is likely required for the differentiation and/or function of microbiota-induced RORγt^+^ iT~reg~ cells^[@R12]^. Moreover, microbe-specific iT~reg~ cells, compared with non-specific nT~reg~, can better suppress inflammatory T~Eff~ cells by recognizing the same epitopes. This result raises the prospect of harnessing the mechanisms of pathobiont-specific iTreg responses to re-establish homeostasis in IBD patients, for example, by engineering non-pathogenic T~reg~-inducing microbes^[@R27]^ to express pathobiont antigens.

METHODS {#S2}
=======

Mice {#S3}
----

Mice were bred and maintained in the animal facility of the Skirball Institute (New York University School of Medicine) and the National Institute of Allergy and Infectious Diseases (NIAID) in specific pathogen-free conditions. C57Bl/6 mice were obtained from Jackson Laboratories or Taconic Farm. *Il10*^−/−^ (B6.129P2-*Il10^tm1Cgn^*/J) mice were purchased from Jackson Laboratories and bred with WT C57Bl/6 mice, which subsequently generated *Il10*^+/−^ and *Il10*^−/−^ littermates by heterozygous breeding. CD4-dnTGFbRII mice^[@R22]^ were purchased from Jackson Laboratories, and bred with WT C57Bl/6 mice to generate CD4-dnTGFbRII and WT littermates. *CD4^cre^* (*Tg(Cd4-cre)1Cwi/BfluJ*) and *CD45.1* (*B6.SJL-Ptprca Pepcb/BoyJ*) mice were purchased from Jackson Laboratories. *Foxp3^creYFP^* mice were previously described and obtained from Jackson Laboratories^[@R28]^. *Il23r^gfp^* and *Maf^fl/fl^* strains were previously described^[@R29],[@R30]^ and kindly provided by Drs. M. Oukka and C. Birchmeier, respectively. *Stat3^fl/fl^;CD4^cre^* mice were kindly provided by Dr. David E. Levy. *Gata3^fl/fl^;Foxp3^creYFP^* mice were bred at the NIAID. Littermates with matched sex (both males and females) were used. Except the aged mice (6--12 month old) analyzed in the experiments of [Fig. 4e](#F4){ref-type="fig"}, mice in all the experiments were 6--12 week old at the starting point of treatments. Animal sample size estimates were determined using power analysis (power=90% and alpha=0.05) based on the mean and standard deviation from our previous studies and/or pilot studies using 4--5 animals per group. All animal procedures were performed in accordance with protocols approved by the Institutional Animal Care and Usage Committee of New York University School of Medicine or the NIAID as applicable.

Antibodies, intracellular staining and flow cytometry {#S4}
-----------------------------------------------------

The following monoclonal antibodies were purchased from eBiosciences, BD Pharmingen or BioLegend: CD3 (145-2C11), CD4 (RM4-5), CD25 (PC61), CD44 (IM7), CD45.1 (A20), CD45.2 (104), CD62L (MEL-14), CXCR5 (L138D7), NPR-1 (3E12), ST2 (RMST2-2), TCRβ (H57-597), TCR Vβ6 (RR4-7), TCR Vβ8.1/8.2 (MR5-2), TCR Vβ14 (14-2), Bcl-6 (K112-91), c-Maf (T54-853), Foxp3 (FJK-16s), GATA3 (TWAJ), Helios (22F6), RORγt (B2D or Q31-378), T-bet (eBio4B10), IL-10 (JES5-16E3), IL-17A (eBio17B7) and IFN-γ (XM61.2). 4′,6-diamidino-2-phenylindole (DAPI) or Live/dead fixable blue (ThermoFisher) was used to exclude dead cells.

For transcription factor staining, cells were stained for surface markers, followed by fixation and permeabilization before nuclear factor staining according to the manufacturer's protocol (Foxp3 staining buffer set from eBioscience). For cytokine analysis, cells were incubated for 5 h in RPMI with 10% FBS, phorbol 12-myristate 13-acetate (PMA) (50 ng/ml; Sigma), ionomycin (500 ng/ml; Sigma) and GolgiStop (BD). Cells were stained for surface markers before fixation and permeabilization, and then subjected to intracellular cytokine staining according to the manufacturer's protocol (Cytofix/Cytoperm buffer set from BD Biosciences).

Flow cytometric analysis was performed on an LSR II (BD Biosciences) or an Aria II (BD Biosciences) and analyzed using FlowJo software (Tree Star).

Isolation of lymphocytes {#S5}
------------------------

Intestinal tissues were sequentially treated with PBS containing 1 mM DTT at room temperature for 10 min, and 5 mM EDTA at 37°C for 20 min to remove epithelial cells, and then minced and dissociated in RPMI containing collagenase (1 mg/ml collagenase II; Roche), DNase I (100 μg/ml; Sigma), dispase (0.05 U/ml; Worthington) and 10% FBS with constant stirring at 37°C for 45 min (SI) or 60 min (LI). Leukocytes were collected at the interface of a 40%/80% Percoll gradient (GE Healthcare). The Peyer's patches and cecal patch were treated in a similar fashion except for the first step of removal of epithelial cells. Lymph nodes and spleens were mechanically disrupted.

Single-cell TCR cloning {#S6}
-----------------------

*Il23r^GFP/+^* mice were maintained in SFB-free conditions to guarantee low T~H~17 background levels. To induce a robust T~H~17 response, the mice were orally infected with *H. hepaticus* and injected intraperitoneally with 1mg anti-IL10RA (clone 1B1.3A, Bioxcell) every week from the day of infection. After two weeks, LI GFP^+^ CD4^+^ T cells were sorted on the BD Aria II and deposited at one cell per well into 96-well PCR plates pre-loaded with 5 μl high-capacity cDNA reverse transcription mix (Thermo Fisher) supplemented with 0.1% Triton X-100 (Sigma-Aldrich). Immediately after sorting, whole plates were incubated at 37 °C for 2 h, and then inactivated at 85°C for 10 min for cDNA preparation. A nested multiplex PCR approach described previously was used to amplify the CDR3α and CDR3β TCR regions separately from the single cell cDNA^[@R31]^. PCR products were cleaned up with ExoSap-IT reagent (USB) and Sanger sequencing was performed by Macrogen. Open reading frame nucleotide sequences of the TCRα and TCRβ families were retrieved from the IMGT database (<http://www.imgt.org>)^[@R32]^.

Generation of TCR hybridomas {#S7}
----------------------------

The NFAT-GFP 58α^−^β^−^ hybridoma cell line was kindly provided by Dr. K. Murphy^[@R33]^. To reconstitute TCRs, cDNA of TCRα and TCRβ were synthesized as gBlocks fragments by Integrated DNA Technologies (IDT), linked with the self-cleavage sequence of 2A (TCRα-p2A-TCRβ), and shuttled into a modified MigR1 retrovector in which IRES-GFP was replaced with IRES-mCD4 (mouse CD4) as described previously^[@R8]^. Then retroviral vectors were transfected into Phoenix E packaging cells using TransIT-293 (Mirus). Hybridoma cells were transduced with viral supernatants in the presence of polybrene (8μg/ml) by spin infection for 90 min at 32 °C. Transduction efficiencies were monitored by checking mCD3 surface expression three days later.

Assay for hybridoma activation {#S8}
------------------------------

Splenic dendritic cells were used as antigen presenting cells (APCs). B6 mice were injected intraperitoneally with 5 × 10^6^ FLT3L-expressing B16 melanoma cells to drive APC proliferation as previously described^[@R34]^. Splenocytes were prepared 10 days after injection, and positively enriched for CD11c^+^ cells using MACS LS columns (Miltenyi). 2 x 10^4^ hybridoma cells were incubated with 10^5^ APCs and antigens in round bottom 96-well plates for two days. GFP induction in the hybridomas was analyzed by flow cytometry as an indicator of TCR activation.

Construction and screen of whole-genome shotgun library of *H. hepaticus* {#S9}
-------------------------------------------------------------------------

The shotgun library was prepared with a procedure modified from previous studies^[@R7],[@R8]^. In brief, genomic DNA was purified from cultured *H. hepaticus* with DNeasy PowerSoil kit (Qiagen). DNA was partially digested with MluCI (NEB), and the fraction between 500 and 2000 bp was ligated into the EcoRI-linearized pGEX-6P-1 expression vector (GE Healthcare). Ligation products were transformed into ElectroMAX DH10B competent Cells (Invitrogen) by electroporation. To estimate the size of the library, we cultured 1% and 0.1% of transformed bacteria on lysogeny broth (LB) agar plates containing 100μg/mL Ampicillin for 12 h and then quantified the number of colonies. The library is estimated to contain 3X10^4^ clones. To ensure the quality of the library, we sequenced the inserts of randomly picked colonies. All the sequences were mapped to the *H. hepaticus* genome, and their sizes were 700 to 1200 bp. We aliquoted the bacteria into 96-well deepwell plates (Axygen) (\~30 clones/well) and grew with AirPort microporous cover (Qiagen) in 37°C. The expression of exogenous proteins was induced by 1mM isopropylthiogalactoside (IPTG, Sigma) for 4 h. Then bacteria were collected in PBS and heat-killed by incubating at 85 °C for 1 h, and stored at −20 °C until use. Two screening rounds were performed to identify the antigen-expressing clones. For the first round, pools of heat-killed bacterial clones were added to a co-culture of splenic APCs and hybridomas. Clones within the positive pools were subsequently screened individually against the hybridoma bait. Finally, the inserts of positive clones were subjected to Sanger sequencing. The sequences were blasted against the genome sequence of *H. hepaticus* (ATCC51449) and aligned to the annotated open reading frames. Full-length open reading frames containing the retrieved fragments were cloned into pGEX-6P-1 to confirm their activity in the T cell stimulation assay.

Epitope mapping {#S10}
---------------

We cloned overlapping fragments spanning the entire HH_1713 coding region into the pGEX-6P-1 expression vector, and expressed these in *E. coli* BL21 cells. The heat-killed bacteria were used to stimulate relevant hybridomas. This process was repeated until we mapped the epitope to a region containing 30 amino acids. The potential MHCII epitopes were predicted with online software RANKPEP^[@R35]^. Overlapping peptides spanning the predicted region were further synthesized (Genescript) and verified by stimulation of the hybridomas.

Generation of TCRtg mice {#S11}
------------------------

TCR sequences of HH5-1 and HH7-2 were cloned into the pTα and pTβ vectors kindly provided by Dr. D. Mathis^[@R36]^. TCR transgenic animals were generated by the Rodent Genetic Engineering Core at the New York University School of Medicine. Positive pups were genotyped by testing TCR Vβ8.1/8.2 (HH5-1tg) or Vβ6 (HH7-2tg) expression on T cells from peripheral blood.

MHCII tetramer production and staining {#S12}
--------------------------------------

HH-E2 tetramer was kindly produced by the NIH Tetramer Core Facility^[@R37]^. Briefly, QESPRIAAAYTIKGA (HH_1713-E2), an immunodominant epitope validated with the hybridoma stimulation assay, was covalently linked to I-A^b^ via a flexible linker, to produce pMHCII monomers. Soluble monomers were purified, biotinylated, and tetramerized with phycoerythrin- or allophycocyanin-labelled streptavidin. SFB-specific tetramer (3340-A6 tetramer) was described previously^[@R8]^. To stain endogenous T cells, mononuclear cells from SILP, LILP or CP were first resuspended in MACS buffer with FcR block, 2% mouse serum and 2% rat serum. Then tetramer was added (10 nM) and incubated at room temperature for 60 min, and cells were re-suspended by pipetting every 20 min. Cells were washed with MACS buffer and followed by regular surface marker staining at 4 °C.

Adoptive transfer of TCRtg cells {#S13}
--------------------------------

Recipient mice were colonized with *H. hepaticus* and/or SFB by oral gavage seven days prior to adoptive transfer (The method for oral infection of SFB has been previously described^[@R8]^). Spleens from donor TCRtg mice were collected and mechanically disassociated. Red blood cells were lysed using ACK lysis buffer (Lonza). For TCRtg mice in WT background, naive Tg T cells were sorted as CD4^+^CD3^+^CD44^lo^CD62L^hi^CD25^−^ Vβ6^+^ (HH7-2tg), Vβ8.1/8.2^+^ (HH5-1tg) or Vβ14^+^ (7B8tg) on the Aria II (BD Biosciences). For HH7-2tg mice bred to the *Foxp3^creYFP^* background, naive Tg T cells were sorted as CD4^+^CD3^+^CD44^lo^CD62L^hi^Foxp3^creYFP−^Vβ6^+^. Cells were resuspended in PBS on ice and transferred into congenic isotype-labeled recipient mice by retro-orbital injection. Cells from indicated tissues were analyzed two weeks after transfer.

*H. hepaticus* culture and oral infection {#S14}
-----------------------------------------

*H. hepaticus* was kindly provided by Dr. James Fox (MIT). Frozen stock aliquots of *H. hepaticus* were stored in Brucella broth with 20% glycerol and frozen at −80°C. The bacteria were grown on blood agar plates (TSA with 5% sheep blood, Thermo Fisher). Inoculated plates were placed into a hypoxia chamber (Billups-Rothenberg), and anaerobic gas mixture consisting of 80% nitrogen, 10% hydrogen, and 10% carbon dioxide (Airgas) was added to create a micro-aerobic atmosphere, in which the oxygen concentration was 3\~5%. The micro-aerobic jars containing bacterial plates were left at 37°C for 5 days before animal inoculation. For oral infection, *H. hepaticus* was resuspended in Brucella broth by application of a pre-moistened sterile cotton swab applicator tip to the colony surface. The concentration of bacterial inoculation dose was determined by the use of a spectrophotometric optical density (OD) analysis at 600 nm, and adjusted to OD~600~ readings between 1 and 1.5. 0.2 mL bacterial suspension was administered to each mouse by oral gavage. Mice were inoculated every 5 days for a total of two doses.

*H. hepaticus*-specific TCRtg cell mediated transfer colitis {#S15}
------------------------------------------------------------

Naïve T (T~naive~) cells were isolated from the spleens of HH7-2tg mice as CD4^+^CD3^+^CD44^lo^CD62L^hi^CD25^−^ Vβ6^+^ by FACS. The sorted cells (1 ×10^3^) were administered by retro-orbital injection into *H. hepaticus*-colonized *Rag1^−/−^* mice. After two weeks, cells from the LI were isolated and analyzed by flow cytometry.

*C. rodentium* mediated colon inflammation {#S16}
------------------------------------------

*C. rodentium* strain DBS100 (ATCC51459; American Type Culture Collection) was used for all inoculations. Bacteria were grown at 37°C in LB broth to OD~600~ reading between 0.4 and 0.6. Mice were inoculated with 200 μl of a bacterial suspension (1--2 × 10^9^ CFU) by way of oral gavage. After 15 days, cells from the LI were isolated, stained for HH-E2 tetramer and other markers as indicated and analyzed by flow cytometry.

DSS-induced colitis {#S17}
-------------------

Mice were colonized with *H. hepaticus* 5 days before dextran sulfate sodium (DSS) treatment. To induce colitis, mice were given 2% DSS (50,000MW, Affymetrix/USB) in drinking water for 2 cycles, with each exposure for 7 days with 5 days of untreated water in between. Control mice were given drinking water for the same period. Cells from the LI were then isolated, stained for HH-E2 tetramer and other marks as indicated and analyzed by flow cytometry. Animal weights were monitored daily during the entire experiment.

T cell culture {#S18}
--------------

Naïve CD4^+^ T cells were purified from spleen and lymph nodes of mice with indicated genotypes. Briefly, CD4^+^ T cells were positively selected from organ cell suspensions by magnetic-activated cell sorting using CD4 beads (MACS, Miltenyi) according to the product protocol, and then isolated as CD4^+^CD3^+^CD44^lo^CD62L^hi^CD25^−^ (polyclonal) or CD4^+^CD3^+^CD44^lo^CD62L^hi^CD25^−^ Vβ6^+^ (HH7-2tg) or Vβ8.1/8.2^+^ (HH5-1tg) by FACS. T cells were cultured at 37°C in RPMI (Hyclone) supplemented with 10% heat-inactivated FBS (Hyclone), 50 U penicillin-streptomycin (Hyclone), 2 mM glutamine (Hyclone), 10mM HEPES (Hyclone), 1mM sodium pyruvate (Hyclone) and 50 μM β-mercaptoethanol (Gibco).

To generate iT~reg~ cells for transfer colitis experiments (see below), WT, HH7-2tg or HH5-1tg cells were seeded at 1x10^6^ cells in 1.5 ml per well in 12-well plates pre-coated with an anti-hamster IgG secondary antibody (MP Biomedicals), and cultured for 72 h. The culture was supplemented with soluble anti-CD3ε (0.25μg/ml, Bioxcell, clone 145-2C11) and anti-CD28 (1μg/ml, Bioxcell, clone 37.51) for TCR stimulation, and anti-IL4 (1μg/ml, Bioxcell, clone 11B11), anti-IFNγ (1μg/ml, Bioxcell, clone XMG1.2), human TGFβ1 (20ng/ml, Peprotech), human IL-2 (500U/ml, Peprotech) and all-trans retinoic acid (100nM, sigma) for optimal iT~reg~ polarization. Aliquots of cultured cells were analyzed for intracellular Foxp3 staining by flow cytometry. After they were confirmed to be \>98% Foxp3^+^, the remaining live cells (DAPI negative) were FACS sorted for adoptive transfer.

To test the conditions inducing c-Maf expression, 200μl naïve T cells isolated from *Maf^fl/fl^*, *Maf^fl/fl^*; *CD4^cre^* or *Stat3^fl/fl^*; *CD4^cre^* mice were seeded at 1x10^5^ cells per well in 96-well plates pre-coated with the anti-hamster IgG secondary antibody, and cultured for 48 h. The culture was supplemented with soluble anti-CD3ε (0.25μg/mL) and anti-CD28 (1μg/mL) for TCR stimulation. Combinations of the following antibodies or cytokines were added as indicated in [Extended Data Fig. 9c](#F13){ref-type="fig"}: anti-TGFβ (1μg/mL, Bioxcell, 1D11.16.8), human TGFβ1 (0.3 or 20ng/ml, Peprotech), human IL-2 (500U/ml, Peprotech), mouse IL-6 (20ng/ml, Thermo), mouse IL-10 (100ng/ml, Peprotech), mouse IL-27 (25ng/ml, Thermo), mouse IL-12 (10ng/ml, Peprotech), mouse IL-1β (10ng/ml, Peprotech), mouse IL-4 (10ng/ml, R&D systems), mouse IFNγ (10ng/ml, Peprotech), and all-trans retinoic acid (100nM, sigma).

T~reg~ cell *in vitro* suppression assay {#S19}
----------------------------------------

T~naive~ cells with the phenotype CD4^+^CD3^+^CD44^lo^CD62L^hi^CD25^−^ were isolated from the spleen and lymph nodes of CD45.1 WT B6 mice by FACS and labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE). nT~reg~ (CD45.2) with the phenotype CD4^+^CD3^+^Foxp3^creYFP+^NRP1^+^ were isolated from the spleen and lymph nodes of *Foxp3^creYFP^* or *Maf*^Δ^*^Treg^* mice by FACS. B cells were isolated from the spleen and lymph nodes of CD45.2 WT B6 mice by positive enrichment for B220^+^ cells using MACS LS columns (Miltenyi). 2.5 × 10^4^ CFSE-labeled T~naive~ cells were cultured for 72 h with B cell APCs (5 ×10^4^) and anti-CD3 (1 μg/ml) in the presence or absence of various numbers of nT~reg~ cells as indicated. The cell division index of responder T cells was assessed by dilution of CFSE using FlowJo software (Tree Star).

Suppression of adoptive transfer colitis with T~reg~ cells {#S20}
----------------------------------------------------------

To compare the suppressive function of c-Maf -sufficient and -deficient nT~reg~ cells, CD4^+^CD3^+^CD25^−^CD45RB^hi^ T~Eff~ cells were isolated by FACS from B6 mouse spleens and CD4^+^CD3^+^Foxp3-YFP^+^NPR1^+^ nT~reg~ were isolated from spleen of *H. hepaticus*-colonized *Foxp3^creYFP^* or *Maf*^Δ^*^Treg^* mice. T~Eff~ cells (5 ×10^5^) were administered by retro-orbital injection into *H. hepaticus*-colonized *Rag1^−/−^* mice alone, or simultaneously with 4 ×10^5^ nT~reg~ as previously described^[@R38]^. Animal weights were measured weekly.

To compare the suppressive function of TCRtg and polyclonal T~reg~ cells, T~naive~ cells with the phenotype CD4^+^CD3^+^CD44^lo^CD62L^hi^CD25^−^ and Vβ6^+^ (HH7-2tg) or CD4^+^CD3^+^CD44^lo^CD62L^hi^CD25^−^ and Vβ8.1/8.2^+^ (HH5-1tg) were isolated from spleens of TCRtg mice. 1,000 naïve HH7-2tg or HH5-1tg cells were co-transferred with different numbers (500,000, 150,000 or 50,000 as indicated in [Fig. 4f, g](#F4){ref-type="fig"}) of *in vitro* polarized (see T cell culture, above) HH7-2tg, HH5-1tg or polyclonal iT~reg~ cells into *H. hepaticus*-colonized *Rag1^−/−^* mice by retro-orbital injection.

Co-housed littermate recipients were randomly assigned to different treatment groups such that each cage contained all treatment conditions. After four to five weeks (for nT~reg~ comparisons) or eight weeks (for the Tg T cell comparisons), large intestines were collected and fixed with 10% neutral buffered formalin (Fisher). Samples were sectioned and stained with hematoxylin and eosin (H&E) by the Histopathology Core at the New York University School of Medicine.

Histology analysis {#S21}
------------------

The H&E slides from each sample were examined in a blinded fashion. Samples of proximal, mid, and distal colon were graded semiquantitatively from 0 to 4 as described previously^[@R39]^. Scores from proximal, mid, and distal sites were averaged to obtain inflammation scores for the entire colon.

Cell isolation for RNA-seq experiment {#S22}
-------------------------------------

A T cell reconstitution system was designed to purify c-Maf-sufficient or -deficient iT~reg~ cells from compatible microenvironments. Briefly, T~naive~ cells were isolated from the spleen of CD45.2 *Foxp3^creYFP^* or *Maf*^Δ^*^Treg^* mice as CD4^+^CD3^+^CD44^lo^CD62L^hi^Foxp3-YFP^−^ and T~reg~ cells were isolated from the spleens of CD45.1 WT B6 mice as CD4^+^CD3^+^CD25^+^ by FACS. T~naive~ cells (2 ×10^5^) and T~reg~ cells (8 ×10^5^) were simultaneously administered by retro-orbital injection into *H. hepaticus*-colonized Rag1^−/−^ mice. Two weeks after transfer, c-Maf-sufficient or -deficient iT~reg~ cells were purified from the LI of reconstituted mice as CD4^+^CD3^+^CD45.1^−^CD45.2^+^Foxp3-YFP^+^ by FACS and collected into FBS. 20% of the sorted cells were stained for RORγt and Foxp3 and the remaining cells were saved in TRIzol (Invitrogen) for RNA extraction.

To isolate *H. hepaticus*-specific colitogenic T effector (T~Eff~) cells, *HH7-2tg;Maf* ^Δ^*^Treg^* and *HH7-2tg;Foxp3^cre^* mice were colonized with *H. hepaticus. HH7-2tg;Foxp3^cre^* mice were further I.P. injected with 1mg anti-IL10RA antibody (clone 1B1.3A, Bioxcell) weekly from the day of colonization. HH7-2 T~Eff~ cells (CD3^+^CD4^+^TCRVβ6^+^Foxp3-YFP^−^) were sorted from the LILP two weeks after colonization. Homeostatic IL-23R-GFP^+^ T cells (CD3^+^CD4^+^IL-23R-GFP^+^) were sorted from both SILP and LILP of *Il23r*^gfp/+^ mice stably colonized with SFB.

RNA-seq library preparation {#S23}
---------------------------

Total RNA was extracted using TRIzol (Invitrogen) followed by DNase I treatment and cleanup with RNeasy MinElute kit (Qiagen). T~reg~ RNA-seq libraries were prepared with the SMART-Seq v4 Ultra Low Input RNA Kit (Clontech cat \# 634899 and 634888). T~H~17 RNA libraries were prepared using the Nugen Ovation Ultralow Library Systems V2 (cat \# 7102 and 0344). All sequencing was performed using the Illumina NextSeq. RNAseq libraries were prepared and sequenced by the Genome Technology Core at New York University School of Medicine.

Data processing of RNA-seq {#S24}
--------------------------

RNA-seq reads were mapped to the *Mus musculus* genome Ensembl annotation release 87 with STAR (v2.5.2b)^[@R40]^. Uniquely mapped reads were counted using featureCounts^[@R41]^ with parameters: -p -Q 20. DESeq2^[@R42]^ was used to identify differentially expressed genes across conditions with experimental design: \~Condition + Gender. Read counts were normalized and transformed by functions varianceStabilizingTransformation and rlog in DESeq2 with the following parameter: blind=FALSE. Gender differences were considered as batch effect, and were corrected by ComBat^[@R43]^. Downstream analysis and data visualization were performed in R^[@R44]^.

Statistical analysis {#S25}
--------------------

For animal studies, mutant and control groups did not always have similar standard deviations therefore unpaired two-sided *Welch's t-test* was used. Error bars represent +/- 1 standard deviation. Animal sample size estimates were determined using power analysis (power=90% and alpha=0.05) based on the mean and standard deviation from our previous studies and/or pilot studies using 4--5 animals. No samples were excluded from analysis. For RNA-seq analysis, differentially expressed genes were calculated in DESeq2 using the Wald test with Benjamini-Hochberg correction to determine FDR. Genes were considered differentially expressed with FDR \< 0.1 and Log2 fold change \> 1.5. Enriched disease pathways in pathogenic HH7-2 T~H~17 were determined using Ingenuity Pathway Analysis ([www.Ingenuity.com](www.Ingenuity.com)). Gene set enrichment analysis (GSEA, <http://www.broad.mit.edu/gsea/>) on *Maf*-deficient vs --sufficient iT~reg~ was performed using a gene set of 33 RORγt-dependent genes in Nrp1^−^ colonic T~reg~ (*RORC, CCR6, IDUA, IL1RN, C2CD4B, NXT1, TMEM176B, CXCR3, TNFRSF1A, ADAMTS7, PIK3IP1, RRAD, CRMP1, IRAK3, FAM129B, PPCS, TBXA2R, AVPI1, SERPINB1A, ALKBH7, NCKIPSD, HAVCR2, IL23R, TXNIP, IGJ, TRIM16, PIGP, RRAS, SAMD10, IL1R2, F2RL1, MAFF, LY6C1*)^[@R11]^.

Data Availability {#S26}
-----------------

cDNA sequences of *H. hepaticus*-specific TCRs yielding data that support the findings of this study have been deposited in GenBank with the accession codes KY964547-KY964570. RNA-seq data can be found under the following accession numbers: SRA (SRP126932), GEO (GSE108184).

Extended Data {#S27}
=============

![Cloning and characterization of *H. hepaticus*-specific T~H~17 TCRs, and generation of TCR transgenic (TCRtg) mice and MHC-II tetramers\
**a,** IL-23R-GFP expression in CD4^+^ T cells from the large intestines of mice with and without *H. hepaticus* colonization and after IL-10Ra blockade. Data are from one of five independent experiments. **b,** Experimental scheme for cloning *H. hepaticus*-induced single IL-23R-GFP^+^ (predominantly T~H~17) cell TCRs under IL-10Ra blockade. **c,** Summary of the twelve dominant *H. hepaticus*-induced T~H~17 TCRs. **d,** *In vitro* activation of CFSE-labeled naive HH7-2tg and HH5-1tg cells by indicated stimuli in the presence of antigen-presenting cells. Data are from one of two independent experiments. **e, f,** Expansion of donor-derived HH7-2tg (**e**) and HH5-1tg (**f**) (CD45.2) cells in the large intestine (LI) of *H. hepaticus*-colonized or -free CD45.1 mice, gated on total CD4^+^ T cells. Data are from one of three independent experiments. **g,** HH-E2 tetramer staining of CD4^+^ T cells from the LI of *H. hepaticus*-colonized or -free mice. Data are from one of six independent experiments.](nihms931786f5){#F5}

![Extended characterization of SFB- and *H. hepaticus-*specific T cells in distinct anatomical sites in bacteria-colonized WT mice\
**a,** Representative flow cytometry plots of donor-derived HH7-2tg (CD45.1/45.2) and 7B8tg (CD45.2/45.2) T cells in indicated tissues of mice colonized with SFB and *H. hepaticus*, gated on total CD4^+^ T cells (CD4^+^CD3^+^) (*n=*15). **b,** Proportions of donor-derived HH7-2tg and 7B8tg T cells among total CD4^+^ T cells in indicated tissues. Data in (**a**) and (**b**) are from one of 3 experiments, with total of 15 mice in the 3 experiments. **c,** Representative flow cytometry plots of RORγt, Foxp3, Bcl6 and CXCR5 expression in CD4^+^ T cells from the host and from HH7-2tg and 7B8tg donors in different tissues (*n=*15). **d,** Frequencies of T~reg~ (Foxp3^+^), T~H~17 (Foxp3^−^RORγt^+^) and T~FH~ (Bcl6^+^CXCR5^+^) cells among donor-derived HH7-2tg and 7B8tg cells in different tissues. Data are from one of 3 experiments, with total of 15 mice in the 3 experiments. **e**, Representative flow cytometry plots of Foxp3, RORγt, GATA3 and ST2 expression in CD4^+^ T cells from the host (blue) and from HH7-2tg donors (red) in the LILP (*n=*5). **f**, Representative flow cytometry plots of Foxp3, RORγt, GATA3 and ST2 expression in total CD4^+^ (green) and HH-E2 tetramer^+^ (red) T cells in the LILP (*n=*5). SILP: small intestinal lamina propria; LILP: large intestinal lamina propria; PP: Peyer's patches; CP: cecal patches; mLNs: mesenteric lymph nodes; and Spl: spleen.](nihms931786f6){#F6}

![Extended characterization of *H. hepaticus*-specific TCRtg cell differentiation\
**a,** HH7-2tg;*Rag1*^−/−^ mice do not develop T~reg~ cells in the thymus. Representative flow cytometry plots of T~reg~ (Foxp3^+^CD25^+^) frequency in indicated tissues of *H. hepaticus*-free HH7-2tg;*Rag1*^+/−^ (*n=*3) or HH7-2tg;*Rag1*^−/−^ (*n=*3) mice. **b, c,** HH7-2tg *Rag1*^−/−^ and *Rag1*^+/−^ donor-derived T cells differentiated into equal frequencies of RORγt^+^ Treg in the LI of WT mice. Equal numbers (2,000) of congenic isotype-labeled HH7-2tg *Rag1*^+/−^ (CD45.1/45.1) and *Rag1*^−/−^ (CD45.1/45.2) naïve T cells were co-transferred into *H. hepaticus*-colonized WT B6 mice. Cells from the LILP were analyzed two weeks after transfer. Data summarize two independent experiments (*n=*6). **b,** Representative flow cytometry plots of donor and recipient T cell frequency (left), and RORγt and Foxp3 expression (right) (*n=*6). **c,** Frequencies of T~reg~ (Foxp3^+^), T~H~17 (Foxp3^−^RORγt^+^) and T~FH~ (Bcl6^+^CXCR5^+^) cells among HH7-2tg *Rag1*^+/−^ (*n=*6) and *Rag1*^−/−^ (*n=*6) donor-derived T cells. **d, e,** 2,000 naïve HH5-1tg cells (CD45.1/45.2) were adoptively transferred into WT B6 mice (CD45.2/45.2) colonized with *H. hepaticus*. Cells from LILP and CP were analyzed two weeks after transfer. **d,** Representative flow cytometry plots are shown for RORγt, Foxp3, Bcl6 and CXCR5 expression in donor-derived and recipient CD4^+^ T cells in indicated tissues. **e,** Frequencies of T~reg~ (Foxp3^+^), T~H~17 (Foxp3^−^RORγt^+^) and T~FH~ (Bcl6^+^CXCR5^+^) among HH5-1tg donor T cells (*n=*8). Data are a summary of eight mice from two independent experiments. All statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are indicated in the figure.](nihms931786f7){#F7}

![Differentiation of SFB- and *H. hepaticus*-specific T cells in *Il10*^+/−^ and *Il10*^−/−^ mice\
**a--d,** Equal numbers (10,000) of congenic isotype-labeled HH7-2tg (CD45.1/45.2) and 7B8tg (CD45.1/45.1) T cells were co-transferred into *Il10^−/−^* and *Il10^+/^*^−^ mice (CD45.2/45.2) colonized with both *H. hepaticus* and SFB. Intestinal T cells were examined two weeks later. **a,** Representative flow cytometry plots of Foxp3, RORγt and T-bet expression in total and Foxp3^−^ host CD4^+^ T cells in the SILP and LILP of *Il10*^+/−^ (*n=*10) and *Il10*^−/−^ (*n=*8) mice that received TCR Tg T cell transplants. **b,** Frequencies of T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^) cells among SILP 7B8tg donor-derived cells in *Il10*^+/−^ (*n=*10) and *Il10*^−/−^ (*n=*8) mice. Data for (**a**) and (**b**) are a summary of four independent experiments. **c,** Representative flow cytometry plots of IL-10, IL-17A and IFNγ expression in transferred 7B8tg and HH7-2tg cells from LILP and SILP of *Il10*^+/−^ and *Il10*^−/−^ mice after re-stimulation (*n=*5 or 6). **d,** Proportions of transferred 7B8tg and HH7-2tg cells in the SILP and LILP of *Il10*^+/−^ and *Il10*^−/−^ mice that express IL-10, IL-17A and IFNγ after re-stimulation (*n* =5 or 6). Data for (**c**) and (**d**) are a summary of two independent experiments. **e,** 2000 naïve HH5-1tg cells (CD45.1/45.2) were adoptively transferred into *Il10*^+/−^ and *Il10*^−/−^ mice colonized with *H. hepaticus*. Cells from the LILP were analyzed two weeks after transfer (*n=*5). Representative flow cytometry plots of RORγt and Foxp3 expression in HH5-1tg donor cells are shown (left), along with a compilation of frequencies of T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^). **f, g,** RORγt and Foxp3 expression in total CD4^+^ and HH-E2 tetramer^+^ T cells (**f**) and frequencies (above) and absolute numbers (below) of T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^) among HH-E2 tetramer^+^ T cells (**g**) in the LILP of *Il10*^+/−^ (day 25, *n=*8) and *Il10*^−/−^ (day-12 *n=*8, day-25 *n=*7, day-42 *n=*8) mice colonized with *H. hepaticus* for indicated times. All statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are as follows: **b,** *i*=0.062 and *ii*=0.063. **e,** *i*=1.46x10^−3^ and *ii*=3.10x10^−4^. **g,** (top) *i*=7.82x10^−4^, *ii*=0.014, *iii*=0.088, *iv*=1.48x10^−4^, *v*=1.47x10^−3^ and *vi*=0.016 and (bottom) *i*=3.85x10^−6^, *ii*=9.63x10^−7^, *iii*=1.31x10^−6^, *iv*=8.91x10^−7^, *v*=1.15x10^−5^ and *vi*=1.56x10^−7^.](nihms931786f8){#F8}

![Differentiation of *H. hepaticus*-specific T cells in colitis models\
**a, b,** Naïve HH7-2tg T cells were adoptively transferred into *H. hepaticus*-colonized *Rag1^−/−^* mice to induce colitis (*n=*7). Data summarize two independent experiments. Representative expression of Foxp3, RORγt, and T-bet (**a**), and a compilation of frequencies of T~reg~ (Foxp3^+^), T~H~17 (Foxp3^−^RORγt^+^), T~H~1 (Foxp3^−^T-bet^+^) and T~H~17/T~H~1 (Foxp3^−^RORγt^+^T-bet^+^) in HH7-2tg donor-derived cells in the LILP of recipient mice was analyzed 4 weeks post transfer. **c--e,** Analysis of *H. hepaticus*-specific T cell differentiation during *C. rodentium*-induced colonic inflammation. Data summarize two independent experiments. **c,** Schematic of experimental design. **d, e,** Representative flow cytometry plots of Foxp3, RORγt and T-bet expression in total CD4^+^ and HH-E2 tetramer^+^ T cells (**d**) and frequencies of T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^) cells among HH-E2 tetramer^+^ T cells (**e**) in the LILP of *C. rodentium*-infected (*n=*5) and -uninfected mice (*n=*5). **f--h,** Analysis of *H. hepaticus*-specific T cell differentiation during DSS-colitis. Data are a summary of two independent experiments. **f,** Schematic of experimental design. **g, h,** Representative flow cytometry plots of Foxp3, RORγt and T-bet expression in total CD4^+^ and HH-E2 tetramer^+^ T cells (**g**) and a compilation of frequencies of T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^) cells among HH-E2 tetramer^+^ cells (**h**) in the LILP of DSS-treated (*n=*10) and -untreated mice (*n=*10). All statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are indicated in the figure.](nihms931786f9){#F9}

![Extended characterization of *Maf* ^ΔTreg^, *Rorc*^ΔTreg^ and *Gata3*^ΔTreg^ animals\
**a,** Expression of c-Maf in the indicated CD4^+^ T cell subsets in the LILP. **b,** Incomplete depletion of c-Maf protein in RORγt^+^ T~reg~ cells in *Maf*^ΔTreg^ mice shown by a representative flow cytometry graph from 3 independent experiments (left), and a compilation of mean fluorescence intensities (MFI) in RORγt^−^ Tregs and residual RORγt^+^ Tregs (right). **c,** Absolute numbers of indicated CD4^+^ T cell populations in the LILP of indicated mice. Data are a summary of 3 independent experiments for *Rorc*^ΔTreg^ (*n=*7) and littermate controls (*n=*7) and 4 independent experiments for *Maf* ^ΔTreg^ (*n=*11) and littermate controls (*n=*8). **d, e,** Representative flow cytometry plots of Foxp3, RORγt and GATA3 expression in total and Foxp3^+^ CD4^+^ T cells (**d**) and a compilation of frequencies of RORγt^+^ and RORγt^−^ T~reg~ (Foxp3^+^) cells and T~H~17 (Foxp3^−^RORγt^+^) cells among total CD4^+^ T cells (**e**) in the LILP of *Gata3*^ΔTreg^ (*n=*8) and littermate controls (*n=*7). Data summarize two independent experiments. **f,** Absolute numbers of indicated HH-E2 tetramer^+^ T cell populations in the LILP of indicated mice. Data are a summary of 3 independent experiments for *Rorc*^ΔTreg^ (*n=*7) and littermate controls (*n=*6) and 4 independent experiments for *Maf* ^ΔTreg^ (*n=*11) and littermate controls (*n=*8). **g**, Representative flow cytometry plots of T~FH~ markers Bcl6 and CXCR5 among total CD4^+^ and HH-E2 tetramer^+^ cells from the CP of *Maf*^ΔTreg^ mice and littermate controls (*n=*4). **h, i,** SFB-specific T cells did not adopt pro-inflammatory T~H~17-T~H~1 phenotype or expand in *Maf*^Δ^*^Treg^* mice. Data summarize two experiments, *Maf*^ΔTreg^ (*n=*5) and littermate controls (*n=*6). Representative flow cytometry plots of Foxp3, RORγt and T-bet expression in total CD4^+^ and SFB-tetramer^+^ T cells (**h**) and absolute number of SFB-tetramer^+^ cells (**i**) in the SILP. All statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are indicated in the figure or as follows: **c,** *i*=0.42, *ii*=0.73, *iii*=6.38x10^−3^, *iv*=2.28x10^−4^, *v*=7x10^−11^, *vi*=7.10x10^−3^, *vii*=2.99x10^−2^ and *viii*=0.83. **e,** *i*=0.081, *ii*=0.102 and *iii*=0.16. **f,** *i*=0.65, *ii*=0.41, *iii*=0.045, *iv*=0.12, *v*=0.29 and *vi*=6.28x10^−3^.](nihms931786f10){#F10}

![Analysis of c-Maf function in RORγt^+^ iT~reg~ cells\
**a--d,** Equal numbers of congenic isotype-labeled naïve *Maf^+/+^;Foxp3^cre^* (Ctrl, CD45.1/45.2) and *Maf^fl/fl^;Foxp3^cre^* (CD45.2/45.2) HH7-2tg cells were co-transferred into *H. hepaticus*-colonized WT CD45.1 mice. Cells from the LILP, mLNs and spleen were analyzed 15 days after transfer. **a,** Schematic of experimental design. **b,** Flow cytometry plot depicting ratio of pooled co-transferred naïve T cells prior to transfer. **c, d,** Left, ratios of *Maf*^Δ^*^Treg^* vs control HH7-2tg donor-derived cells in the mLNs and spleen (n=10). Dashed line represents ratio of co-transferred cells prior to transfer. Right, frequencies of T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^) among donor-derived cells (n=10). Statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are indicated in the figure. **e--h,** Isolation of *Maf*-deficient and -sufficient iT~reg~ cells for RNA-seq through a T cell reconstitution system. Two replicates represent two independent experiments. **e,** Schematic of experimental design. **f,** Flow cytometry plots indicating the sorting gates from two independent experiments. **g**, Flow cytometry plots showing Foxp3 and RORγt expression in sorted Foxp3-YFP^+^ cells from two independent experiments. **h**, Gene Set Enrichment Analysis performed on RNA-seq dataset of c-Maf-sufficient vs. -deficient iTreg (Foxp3-YFP^+^) cells (n=2 independent experiments) with gene set of 33 RORγt-dependent transcripts identified previously^[@R11]^. **i,** Top, representative flow cytometry plot of c-Maf expression in T~H~17 cells (Foxp3^−^ RORγt^+^) from LILP of control (black) and *Maf* ^ΔTreg^ (red) mice. The c-Maf negative population is defined by gating on Foxp3^+^RORγt^−^ T~reg~ from *Maf*^ΔTreg^ mice (solid grey). Bottom, frequency of c-Maf expression in Th17 cells in control (n=6) and *Maf* ^ΔTreg^ (n=9) mice from 3 independent experiments.](nihms931786f11){#F11}

![Transcriptional profiling of conventional T~H~17 and *H. hepaticus*-specific T effector cells\
**a--f,** RNA-seq was performed on 2 biological replicates of each indicated condition. **a,** Flow cytometry analysis of HH7-2tg T effector cells from *H. hepaticus*-colonized mice and conventional IL-23R-GFP^+^ (predominantly SFB-specific T~H~17) cells from SFB-colonized mice. GFP^+^ gates in the lower panel were used for sorting to perform RNA-seq. **b,** Principal component analysis of RNA-seq data from sorted cell populations. Colored dots represent individual samples (*n*=2). **c, e, f,** Differentially expressed genes were calculated in DESeq2 using the Wald test with Benjamini-Hochberg correction to determine FDR. Genes were considered differentially expressed when FDR\<0.1 and Log2 fold change \> 1.5. **c,** Venn diagram depicting differentially expressed genes between indicated comparisons. **d,** Significantly enriched disease pathways in the set of 149 shared genes upregulated in HH7-2tg *Maf* ^ΔTreg^ and HH7-2tg from anti-IL-10RA-treated mice compared to conventional LI T~H~17. *P*-values calculated by Ingenuity Pathway Analysis using Fisher's Exact Test. **e,** Comparison of transcriptomes of *H. hepaticus*-specific T~H~17 cells from mice treated with IL-10Ra blockade or *Maf*^Δ^*^Treg^* and conventional T~H~17 cells. Scatter plot depicting log2 fold change of gene expression. Blue, red and purple dots indicate significant difference. **f,** Heatmap depicting the 347 shared genes differentially expressed between pathogenic HH7-2 and conventional T~H~17 cells (purple dots in **e**). Data for each condition are the mean of 2 biological replicates. Scale bar represents z-scored variance stabilized data (VSD) counts.](nihms931786f12){#F12}

![Stat3 and TGFβ signal synergistically to promote c-Maf expression\
**a,** Above, representative flow cytometry plots depicting RORγt and Foxp3 expression in CD4^+^ T cells in the LILP of CD4-dnTGFbRII and littermate controls (n=3). Below, representative plot of c-Maf expression in Foxp3^+^ cells from above animals. **b,** Above, representative flow cytometry plots depicting RORγt and Foxp3 expression in CD4^+^ T cells in the LILP of *Stat3^fl/fl^*; *CD4^Cre^* and *Stat3^fl/fl^* littermate controls (n=4). Below, representative plot of c-Maf staining in Foxp3^+^ cells from above animals. **c,** Mean fluorescence intensity of c-Maf staining in *in vitro* differentiated CD4^+^ T cells. Naïve CD4^+^ T cells from WT, *Stat3^fl/fl^;CD4^Cre^* and *Maf^fl/fl^;CD4^cre^* mice were activated for 48 h with α-CD3ε/α-CD28 under indicated conditions. Dashed line represents the MFI of c-Maf in *Maf^fl/fl^;CD4^cre^* T cells. Data shows one of two independent experiments.](nihms931786f13){#F13}

![c-Maf-deficient nT~reg~ cells retain suppressive function\
**a,** Equivalent inhibitory function of nT~reg~ cells from *Maf* ^ΔTreg^ and control mice in the *in vitro* proliferative response of CD4^+^ T cells (T~Eff~). Three data points are from one of two independent replicates. **b,** Activity of nTreg cells in the transfer-mediated colitis model. Percentage weight change (left) and colitis histology scores (right) of *Rag*1^−/−^ mice adoptively transferred with naïve T cells alone (n=8), or naïve T cells in combination with nT~reg~ cells from *Maf* ^ΔTreg^ (n=10) or littermate control *Foxp3^creYFP^* (n=9) mice. Data are a summary of two independent experiments. All statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are indicated in the figure.](nihms931786f14){#F14}
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![*H. hepaticus* induces RORγt^+^ T~reg~ and T~FH~ responses under steady state\
**a,** Experimental scheme for co-transfer of congenic isotype-labeled HH7-2tg and 7B8tg cells into wild type (WT) mice colonized with *H. hepaticus* and SFB. **b, c,** RORγt, Foxp3, Bcl-6 and CXCR5 expression (**b**) and frequencies of T~reg~ (Foxp3^+^), T~H~17 (Foxp3^−^RORγt^+^) and T~FH~ (Bcl6^+^CXCR5^+^) (**c**) among donor-derived T cells in indicated tissues. Data are from one of 3 experiments, with n=15 in the 3 experiments. **d, e,** WT mice (*n=*6) were colonized with *H. hepaticus* for 3--4 weeks and analyzed for RORγt, Foxp3 and Bcl6 expression in total CD4^+^ (red) and HH-E2 tetramer^+^ (blue) T cells from the LILP (**d**) and frequencies of T~reg~ (Foxp3^+^), T~H~17 (Foxp3^−^RORγt^+^) and T~FH~ (Bcl6^+^) among HH-E2 tetramer^+^ T cells in the LILP and CP (**e**). Data summarize two independent experiments. SILP: small intestinal lamina propria; LILP: large intestinal lamina propria; PP: Peyer's patches and CP: cecal patch.](nihms931786f1){#F1}

![*H. hepaticus* predominantly induces inflammatory T~H~17 cells in IL-10 deficiency-dependent colitis\
**a--d,** LILP HH7-2tg and SILP 7B8tg donor-derived cells in *Il10*^+/−^ (*n=*8) and *Il10*^−/−^ (*n=*10) mice were analyzed for Foxp3 and RORγt expression (**a**), frequencies of T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^) (**b**), RORγt and T-bet co-expression (**c**), and frequencies of T-bet expression among T~H~17 (Foxp3^−^RORγt^+^) cells (**d**). Data are from four independent experiments. **e, f,** IL-17A and IFNγ expression (**e**) and frequencies of IL-10, IL-17A and IFNγ positive cells (**f**) among LILP HH7-2tg donor-derived cells in *Il10*^+/−^ (*n=*5) and *Il10*^−/−^ (*n=*6) mice after re-stimulation. Data summarize two independent experiments. All statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are as follows: **b,** *i*=9.48x10^−12^ and *ii*=1.11x10^−13^. **d,** *i*=2.16x10^−9^, *ii*=1.22x10^−10^ and *iii*=0.36.](nihms931786f2){#F2}

![c-Maf is required for the differentiation and function of induced T~reg~ cells in the gut\
**a, b,** Transcription factor staining in total CD4^+^ (**a**) and HH-E2 tetramer^+^ (**b**) T cells from the LILP of indicated mice. Left panels: RORγt and Foxp3 expression. Right panels: frequencies of indicated T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^) subsets. Mice were colonized with *H. hepaticus* for 5\~6 weeks before analysis. Data summarize 3 independent experiments for *Rorc*^Δ^*^Treg^* (*n=*7) and littermate controls (*n=*7 for panel **a** and *n*=6 for **b**), and 4 independent experiments for *Maf*^Δ^*^Treg^* (*n=*10) and littermate controls (*n=*8). **c--e,** Co-transfer of *Maf*^Δ^*^Treg^* and control HH7-2tg T cells into WT *H. hepaticus*-colonized mice. **c,** Left: donor cell composition in the LILP of recipient mice. Right: RORγt and Foxp3 expression in indicated donor-derived cells. **d,** Ratios of *Maf*^Δ^*^Treg^* vs control HH7-2tg donor-derived cells in the LILP. Dashed line represents ratio of co-transferred cells prior to transfer. **e,** Frequencies of T~reg~ (Foxp3^+^) and T~H~17 (Foxp3^−^RORγt^+^) cells among donor-derived cells. Data are a summary of 10 mice from 2 independent experiments. **a, b, e,** Statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are as follows: **a,** *i*=1.21x10^−6^, *ii*=8.82x10^−7^, *iii*=0.016, *iv*=6.38x10^−4^, *v*=8.06x10^−4^ and *vi*=9.89x10^−7^. **b,** *i*=0.056, *ii*=7.48x10^−4^, *iii*=7.64x10^−7^ and *iv*=6.01x10^−6^. **e,** *i*=6x10^−14^ and *ii*=0.86. **f**, MA plot depicting RNA-seq comparison of donor naïve T cell-derived *Maf*^Δ^*^Treg^* vs. control Foxp3-YFP^+^ iT~reg~ cells (mean of 2 biologically independent experiments). Blue dots indicate 190 up-regulated and 75 down-regulated genes in c-Maf-dependent signature. Highlighted blue dots represent down-regulated genes related to T~reg~ function and highlighted red dots indicate genes that are also dependent on RORγt^[@R11]^. Differentially expressed genes were calculated in DESeq2 using the Wald test with Benjamini-Hochberg correction to determine FDR (FDR\<0.1 and Log2 fold change \> 1.5).](nihms931786f3){#F3}

![RORγt^+^ iT~reg~ cells are required to maintain gut homeostasis\
**a,** Frequency of rectal prolapse by genotype. **b,** Spleens and mesenteric lymph nodes (mLNs) from *Maf*^Δ^*^Treg^* and littermate controls (left). Total cell numbers in mLNs (right). Data summarize 3 independent experiments for *Rorc*^Δ^*^Treg^* (*n=*6) and littermate controls (*n=*7), and 4 independent experiments for *Maf*^Δ^*^Treg^* (*n=*9) and littermate controls (*n=*8). **c,** Number of leukocytes in the LILP. Data summarize 3 independent experiments for *Rorc*^Δ^*^Treg^* (*n=*7) and littermate controls (*n=*8), and 4 independent experiments for *Maf*^Δ^*^Treg^* and littermate controls (*n=*9). **d,** Representative histology of LI sections (left) and colitis scores (right) of mice with indicated genotypes. *Rorc*^Δ^*^Treg^* (*n=*8) and littermate controls (*n=*9). *Maf*^Δ^*^Treg^* (*n=*11) and littermate controls (*n=*9). **e,** Colitis scores in aged *H. hepaticus*-negative *Maf*^Δ^*^Treg^* (*n=*6) and littermate control (*n=*7) mice. **f, g,** Suppression of *H. hepaticus*-specific TCRtg cell mediated transfer colitis by *in vitro* differentiated iT~reg~. Data summarize 2 independent experiments with indicated sample size (*n*) in total. Colitis scores for *Rag1^−/−^* mice that received the indicated TCRtg naïve T cells and iT~reg~ combinations. All statistics were calculated by unpaired two-sided *Welch's t-*test. Error bars: mean ± 1 SD. *P* values are indicated in the figure or as follows: **f,** *i*=5.34x10^−4^, *ii*=1.24x10^−2^, *iii*=3.64x10^−4^, *iv*=0.056, *v*=3.26x10^−4^ and *vi*=4.54x10^−3^. **g,** *i*=0.013, *ii*=2.50x10^−3^, *iii*=4.59x10^−4^, *iv*=0.024, *v*=0.12 and *vi*=0.016.](nihms931786f4){#F4}
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